MCM PRV Reauthorization Act

Hozzl · 2024-02-05T14:30:09Z

Explore the details of House Bill 5708 MCM PRV Reauthorization Act currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

2/5/2024, 2:30 PM

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HR 5708

Bill HR 5708 is currently in the status of Bill Introduced since September 26, 2023. Bill HR 5708 was introduced during Congress 118 and was introduced to the House on September 26, 2023. Bill HR 5708's most recent activity was Referred to the Subcommittee on Health. as of September 29, 2023

Bipartisan Support of Bill HR 5708

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 5708

Primary Policy Focus

Health

Alternate Title(s) of Bill HR 5708

MCM PRV Reauthorization Act

To amend the Federal Food, Drug, and Cosmetic Act to extend a priority review program to encourage treatments for agents that present national security threats.